We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Breast Implants Contain RFID Technology

By HospiMedica International staff writers
Posted on 02 Mar 2014
Breast implants with radiofrequency identification (RFID) chips can be simply externally scanned for retrieval of information in the event of a recall or other product query.

The Motiva Implant Matrix VelvetSurface PLUS and SilkSurface PLUS breast implants are a made of a soft, gliding, printed nanosurface that reduces complications related to traditional textures, while at the same time reducing capsular contracture rates. More...
The VelvetSurface PLUS implants also provide a printed microsurface that promotes a more secure fit in the breast pocket. Both breast implants are provided with Q Inside Safety Technology, which acts as an electronic serial identification number in breast implants and other implantable and reusable medical devices.

Manufacturers, physicians, and patients alike will have access to a secure online database to retrieve implant-specific data such as serial number, manufacturer name, date of manufacture, lot number, volume, size, and other data from the medical device manufacturer. The Motiva Implant Matrix VelvetSurface PLUS and SilkSurface PLUS breast implants are products of Establishment Labs (Alajuela, Costa Rica). Q Inside Safety Technology was developed by VeriTeQ Corporation (DelRay Beach, FL, USA), a provider of implantable medical device identification and radiation dose measurement technologies.

“We continue to advance the safety and exclusivity of our entire breast implant portfolio to answer the demands from both physicians and patients alike,” said Juan José Chacón-Quirós, CEO of Establishment Labs. “Including VeriTeQ’s Q Inside Safety Technology in Motiva’s SilkSurface PLUS and VelvetSurface PLUS implants emphasizes our primary focus of providing best-in-class products for the protection of the patient.”

“Giving physicians and patients the power to identify their breast implants in a healthcare setting is the next generation of technology and security, and we believe both groups will ultimately demand this level of safety from their implants,” said Scott R. Silverman, chairman and CEO of VeriTeQ.

A example highlighting the need for breast implant identification occurred in 2010, when a French manufacturer of breast implants named PIP was shut down because the company used industrial grade silicone in their implants instead of medical-grade silicone, which had double the rupture rate of other implants. As news of leaks spread, breast implant patients were concerned that they may have PIP's implants. Many of the patients did not have product or warranty cards, and no records were available on which implants were inside each patient.

Related Links:

Establishment Labs
VeriTeQ Corporation



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.